Next Call Could Be Regulators After hGH Direct Seller Ignores Industry Self-Regulation Process
Executive Summary
Direct seller New U Life may face regulatory scrutiny after two BBB National Programs, Inc. industry self-regulation programs reported it failed to stop using bogus health claims, including treating COVID-19.
You may also be interested in...
Risking FTC Scrutiny, Direct Seller Ignores Industry Self-Regulation Group On COVID-19 Claims
Direct seller Flavon USA is referred to FTC after it failed to respond to repeated outreach by Direct Selling Self-Regulatory Council over claims its supplements treat coronavirus. The watchdog asked for substantiation of claims suggesting products also could tumors and diabetes.
Federal Agencies Shut Down Church Group's Sales Of Bleach Mixture Promoted As COVID-19 Cure
The combination of Genesis II Church's rejection of FDA's warning, the potential for serious adverse events linked to its chlorine dioxide formulation and its claims the product treats COVID-19 led FDA to seek an injunction to stop sales of the product a week after it warned the group.
Somaderm 'FDA Registered' But Not 'Approved' – Similac-Enfamil Comparison Also Reviewed
Similac marketer Abbott Nutrition supports most but not all ad claims comparing its Human Milk Fortifier to Enfamil's; Council of Better Business Bureaus' investigative arms review claims comparing two baby probiotic drop brands and a protein digesting enzyme ad.